Maxum's revenues improved in 1995

Article

Imaging services firm Maxum Health reported its last year of financialresults as a separate company before it is merged with AmericanHealth Services (SCAN 3/13/96). The Dallas company reported higherrevenues for 1995 (end-December), due in part to

Imaging services firm Maxum Health reported its last year of financialresults as a separate company before it is merged with AmericanHealth Services (SCAN 3/13/96). The Dallas company reported higherrevenues for 1995 (end-December), due in part to several imagingcenter acquisitions made last year, although the company fellback into the red after a profitable 1994.

For the year, Maxum had revenues of $50.6 million, up 10% overthe $45.9 million in sales reported in 1994. The company posteda net loss of $4.3 million for the year, compared with a $4.2million profit in 1994.

Maxum's operating loss narrowed, however, to $1.2 million in1995 from $2.8 million the year before, when Maxum recorded aone-time gain of $3.3 million on extinguishment of debt and a$4.8 million gain on the sale of its lithotripsy business. Maxumalso took a $1.5 million charge last year to settle securitieslitigation filed in 1993.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.